BIOMAT Database Logo BIOMAT Database Logo

Highly potent HIV-1 protease inhibitors with novel tricyclic P2 ligands: design, synthesis, and protein-ligand X-ray studies. 2013

Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Department of Chemistry and Department of Medicinal Chemistry, Purdue University , West Lafayette, Indiana 47907, United States.

The design, synthesis, and biological evaluation of a series of HIV-1 protease inhibitors incorporating stereochemically defined fused tricyclic P2 ligands are described. Various substituent effects were investigated to maximize the ligand-binding site interactions in the protease active site. Inhibitors 16a and 16f showed excellent enzyme inhibitory and antiviral activity, although the incorporation of sulfone functionality resulted in a decrease in potency. Both inhibitors 16a and 16f maintained activity against a panel of multidrug resistant HIV-1 variants. A high-resolution X-ray crystal structure of 16a-bound HIV-1 protease revealed important molecular insights into the ligand-binding site interactions, which may account for the inhibitor's potent antiviral activity and excellent resistance profiles.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D016333 HIV Protease Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. HIV Proteinase,HTLV-III Protease,p16 pol gene product, HIV,p16 protease, HIV,HIV p16 protease,HTLV III Protease,Protease, HIV,Protease, HTLV-III
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Structure-Based Design of Highly Potent HIV-1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X-ray Structural Studies.
May 2020, Journal of medicinal chemistry,
Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands.
June 2014, Bioorganic & medicinal chemistry letters,
Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis.
May 2018, Journal of medicinal chemistry,
Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Potent HIV-1 protease inhibitors incorporating meso-bicyclic urethanes as P2-ligands: structure-based design, synthesis, biological evaluation and protein-ligand X-ray studies.
October 2008, Organic & biomolecular chemistry,
Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Design, Synthesis, and X-ray Studies of Potent HIV-1 Protease Inhibitors with P2-Carboxamide Functionalities.
October 2020, ACS medicinal chemistry letters,
Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Flexible cyclic ethers/polyethers as novel P2-ligands for HIV-1 protease inhibitors: design, synthesis, biological evaluation, and protein-ligand X-ray studies.
October 2008, Journal of medicinal chemistry,
Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Design, Synthesis and X-Ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-Furofuran Derivatives as P2 Ligands.
May 2022, ChemMedChem,
Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Design, synthesis, X-ray studies, and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1'-P2' ligands.
November 2017, Bioorganic & medicinal chemistry letters,
Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands.
June 2011, Bioorganic & medicinal chemistry letters,
Arun K Ghosh, and Garth L Parham, and Cuthbert D Martyr, and Prasanth R Nyalapatla, and Heather L Osswald, and Johnson Agniswamy, and Yuan-Fang Wang, and Masayuki Amano, and Irene T Weber, and Hiroaki Mitsuya
Design, Synthesis, Biological Evaluation, and X-ray Studies of HIV-1 Protease Inhibitors with Modified P2' Ligands of Darunavir.
December 2017, ChemMedChem,
Copied contents to your clipboard!